5–13. In mid-2008, Fresenius, a German manufacturer of dialysis equipment, acquired APP Pharmaceuticals for $4.6 billion. The deal includes an earn-out, under which Fresenius would pay as much as $970 million if APP reaches certain future financial targets. What is the purpose of the earn-out? How does it affect the buyer and seller?